Table 2.
Time to treatment initiation after hepatitis C screening in the general population and subgroups per year, 2015-2019.
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|
| Number of patients with incident-initiated treatment and HCV screening | N | 12,517 | 13,789 | 15,896 | 10,781 | 6,796 |
| Interval*between test and initiation of treatment, days | Median | 64.0 | 77.0 | 60.0 | 53.0 | 37.0 |
| Q1 - Q3 | [8.0 -171.0] | [24.0 - 168.0] | [20.0 - 123.0] | [21.0 - 107.0] | [16.0 - 75.0] | |
| Number of psychiatric patients with incident-initiated treatment and HCV screening | N | 3,326 | 3,641 | 3,972 | 2,811 | 1,722 |
| Interval*between test and initiation of treatment, days | Median | 70.0 | 84.0 | 62.0 | 55.0 | 38.0 |
| Q1 - Q3 | [8.0 -196.0] | [25.0 -187.0] | [21.0 -131.0] | [21.0 -115.0] | [16.0 -78.0] | |
| Number of HIV-patients with incident-initiated treatment and HCV screening | N | 2,158 | 1,728 | 1,019 | 763 | 542 |
| Interval*between test and initiation of treatment, days | Median | 57.0 | 43.5 | 51.0 | 38.0 | 20.0 |
| Q1 - Q3 | [7.0 -168.0] | [5.0 -120.0] | [11.0 -122.0] | [10.0 -95.0] | [6.0 -50.0] | |
| Number of DU with incident-initiated treatment and HCV screening | N | 2,263 | 2,726 | 2,997 | 2,333 | 1,548 |
| Interval*between test and initiation of treatment, days | Median | 86.0 | 88.0 | 70.0 | 60.0 | 40.0 |
| Q1 - Q3 | [20.0 -244.0] | [31.0 -199.0] | [27.0 -146.0] | [22.0 -124.0] | [19.0 -83.0] |
⁎
The interval was calculated using the last test performed before the initiation of treatment during the study period.